Zeal Life Sciences Pty Ltd is a privately held firm based in New South Wales, Australia. Al Mousawi Medical group., one of our affiliates, is situated in Kuwait. We started with the goal of commercializing speciality medications in emerging markets.

We focus on innovative generic formulations and co-developing and commercializing biological products through our headquarters. We locally register, produce, and market speciality medications through our facilities in developing and emerging countries.

In the Middle East, Australia, Europe, North Africa, South America, and Southeast Asia, we want to invest in the development of these markets. We are currently operating in the middle east and are looking to expand our business to other markets.

The following are some of the advantages that countries that are well suited for development have to offer:

• A huge population base with a high rate of growth.
• A high GDP combined with large health-care spending

Institutions that can help include:

• Hospitals that are well-established and growing
• Insurance coverage is being expanded by payers.
• Rising government encouragement of joint purchase, generics consumption, and local pharmaceutical production.
• There are a number of well-known champions who desire to be a part of the pharmaceutical transition.